| 영문 | malignant tumor | 한글 | 악성종양 |
|---|---|---|---|
| 설명 | 정상적인 조직 세포가 각종 물리적-화학적-생물학적인 발암 물질의 작용 또는 요인에 의해 돌연변이를 일으켜서 형성되는 종양. 무제한의 세포분열로 매우 왕성하게 증식하여 주위조직을 파괴-침식한다. 또 어떤 화학물질을 내어 주위의 조직세포를 침해할 뿐만 아니라, 혈관 및 림프관을 따라 전이하여 전신의 카켁시아를일으켜 죽음을 초래한다. 상피성인 것을 암종이라 하고, 비상피성인 것을 육종이라 한다. |
||
| 영문 | carcinoid | 한글 | 카르시노이드 |
|---|---|---|---|
| 설명 | 주로 막창자꼬리에 발생하는 종양, 비교적 경계가 명확한 노란색을 띠는 극히 드물고 침윤성장을 하며, 종양으로서 작은창자, 막창자꼬리를 포함한 위창자관에 흔하지만 어떤장기에도 생길 수 있다. 조직학적으로 신경내분비세포기원의 세포로 구성되고 경우에 따라 serotonin을 분비하여 카르시노이드증후군을 일으킬 수 있다. 악성도는 보통이며, 전이하는 경우도 있다. 원발성 종양은 보통 앵두 크기의 결절이며 황색을 띤 회백색이다. 조직학적으로는 크기가 균등하고 둥근 핵이 있는 작은 종양세포가 집단적으로 증식해 있다. 그 세포질에 도은법이라고 하는 일종의 염색법을 행하면 은을 환원하는 과립이 증명된다. 이 종양세포는 세로토닌이라는 물질을 분비하기 때문에 피부혈관의 확장, 기관지 수축에 의한 천식과 비슷한 발작, 우심기능상실에 의한 심장발작, 설사와 복통 등 특유한 증세를 나타내는 수가 있다. |
||
| 영문 | malignant melanoma | 한글 | 악성흑색종 |
|---|---|---|---|
| 설명 | 피부에서 생기는 암의 일종. 주로 백인에게 호발하며, 50대~70대에 많이 발생하고, 젊은 여성에게 증가하는 경향이 있으며, 피부암중 1~3%를 차지하는 드문 병으로 피부와 기타 기관의 멜라닌 세포계에서 유래하는 악성종양이다. 원인으로 일광노출과 직접적인 관계가 있으며 가족적 발생도 볼 수 있다. |
||
| 영문 | solid tumor | 한글 | 고형종양 |
|---|---|---|---|
| 설명 | 세포로 꽉 찬 종양을 말함. 백혈병 등의 혈액암과 같이 형태를 취하지 않고 액체인 상태의 암과 대조되는 용어로서 단단한 덩어리로 구성된 악성종양이다. 대부분의 종양이 이에 해당한다. 특히 표피조직에서 기원한 종양을 말한다. |
||
| 영문 | ulcerating tumor | 한글 | 궤양성 종양 |
|---|---|---|---|
| 설명 | 종양의 표면에 궤양이 발생하는 것. 대개, 매우 빨리 자라는 종양에서 혈류 공급이 종양세포의 자라는 속도를 감당하지 못해 종양중심부 조직이 괴사에 빠져 궤양을 형성하는 경우가 많다. 육안으로 보면 빨갛고, 열이나며, 지저분해 보인다. |
||
| MH | malignant histiocytosis; malignant hyperpyrexia; malignant hypertension; malignant hyperthermia; mam... |
|---|---|
| MHS | major histocompatibility system; malignant hyperthermia in swine; malignant hyperthermia syndrome; m... |
| MCS | malignant carcinoid syndrome; managed care system; massage of the carotid sinus; mesocaval shunt; me... |
| PCT | peripheral carcinoid tumor; plasma clotting time; plasmacrit test; plasmacytoma; polychlorinated tri... |
| CS | calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ... |
| AC | atypical carcinoid |
|---|---|
| TC | typical carcinoid |
| MMMT | Malignant Mixed Mesodermal Tumor |
| MMMT | Malignant mixed Mullerian tumor |
| MRT | Malignant rhabdoid tumor |
| malignant carcinoid syndrome | <syndrome> A symptom complex associated with carcinoid tumour and characterised by attacks of severe flushing of the skin, diarrhoeal watery stools, bronchoconstriction, sudden drops in blood pressure, oedema, and ascites. The carcinoid tumours are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumour secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute carcinoid heart disease. (12 Dec 1998) |
|---|---|
| tumor | 1. <oncology> An abnormal mass of tissue that results from excessive cell division that is uncontrolled and progressive, also called a neoplasm. Tumours perform no useful body function. They may be either benign (not cancerous) or malignant. 2. Swelling, one of the cardinal signs of inflammations, morbid enlargement. Origin: L. Tumere = to swell (12 May 1997) |
| tumor marker | <investigation, oncology> A substance in the body that usually indicates the presence of cancer. These markers are usually specific to certain types of cancer and are usually found in the blood or other tissue samples. Examples are alphafetoprotein (AFP), human chorionic gonadotropin, and lactate dehydrogenase (LDH). They may be indicators of tumour stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids. (18 Jul 2002) |
| tumor necrosis factor | <cytokine> Originally described as a tumour inhibiting factor in the blood of animals exposed to bacterial lipopolysaccharide or Bacille Calmette-Guerin. Preferentially kills tumour cells in vivo and in vitro, causes necrosis of certain transplanted tumours in mice and inhibits experimental metastases. Human Tumour Necrosis factor alpha is a protein of 157 amino acids and has a wide range of pro inflammatory actions. Usually considered a cytokine. Synonym: cachectin. Acronym: TNF (13 Nov 1997) |
| carcinoid | <oncology, tumour> Intestinal tumour arising from specialised cells with paracrine functions (APUD cells). The primary tumour is commonly in the appendix, where it is clinically benign, hepatic secondaries may release large amounts of vasoactive amines such as serotonin to the systemic circulation. Synonym: argentaffinoma. (19 Jan 1998) |
| carcinoid flush | Periodic hyperaemia (flushing) of the skin of the face and other parts of the body seen in patients with a carcinoid tumour; the mediator has not been identified but it is not serotonin; flush can be precipitated by alcohol, food, stress, or palpation of the liver. (05 Mar 2000) |
| carcinoid heart disease | Cardiac manifestation of malignant carcinoid syndrome. It is a unique form of fibrosis involving the endocardium, primarily of the right heart. The fibrous deposits tend to cause constriction of the tricuspid and pulmonary valves. (12 Dec 1998) |
| carcinoid syndrome | <oncology, syndrome> A constellation of symptoms associated with a serotonin-secreting neoplasm known as carcinoid tumour. These tumours may grow anywhere in the gastrointestinal tract (and in the lungs) with approximately 90% in the appendix. The remainder occur in the ileum, stomach, colon or rectum. Symptoms include flushing, rapid pulse, facial swelling, swelling around the eyes, low blood pressure, abdominal pain, weight loss and diarrhoea. (19 Jan 1998) |
| carcinoid tumour | A tumour which secretes excessive amounts of the hormone serotonin. The clinical result is carcinoid syndrome. These tumours may grow anywhere in the gastrointestinal tract (and in the lungs) with approximately 90% in the appendix. The remainder occur in the ileum, stomach, colon or rectum. (27 Sep 1997) |
| metastatic carcinoid syndrome | <oncology, syndrome> A constellation of symptoms associated with a serotonin-secreting neoplasm known as carcinoid tumour. These tumours may grow anywhere in the gastrointestinal tract (and in the lungs) with approximately 90% in the appendix. The remainder occur in the ileum, stomach, colon or rectum. Symptoms include flushing, rapid pulse, facial swelling, swelling around the eyes, low blood pressure, abdominal pain, weight loss and diarrhoea. (19 Jan 1998) |
| cancer, malignant melanoma | A skin cancer that begins in cells called melanocytes that can grow together to form benign (not cancerous) moles. A change in size, shape, or colour of a mole can be a sign of melanoma. Melanoma can be cured if detected early, before spread (metastasis) to other areas of the body. Diagnosis is confirmed with a biopsy of the abnormal skin. Sun exposure can cause skin damage that can lead to melanoma. (12 Dec 1998) |
| canine malignant lymphoma | <tumour> A progressive fatal disease of dogs characterised by neoplastic transformation and proliferation of lymphoid cells, usually originating in solid lymphoid organs (lymphosarcoma) or bone marrow (lymphocytic leukaemia). (05 Mar 2000) |
| malignant | <oncology> Tending to become progressively worse and to result in death. Having the properties of anaplasia, invasion and metastasis, said of tumours. Origin: L. Malignans = acting maliciously (18 Nov 1997) |
| malignant anaemia | <haematology> A form of anaemia (low red blood cell counts) that results when the bone marrow fails to produce adequate numbers of red blood cells due to a deficiency in vitamin B12. Intrinsic factor, necessary for normal B12 absorption, may be the underlying cause for B12 deficiency if is not produced in the gastric glands (in the stomach). Origin: Gr. Haima = blood (27 Sep 1997) |
| malignant catarrh | A herpes virus infection of cattle characterised by catarrhal inflammation of the upper respiratory and alimentary epithelia, keratoconjunctivitis, encephalitis and lymph node enlargement. Syn: bovine epitheliosis, snotsiekte. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|